Solventum

Solventum is a planned independent company focused on health technology, to be spun off from 3M's healthcare business. The company will encompass 3M's businesses in wound care, oral care, healthcare IT, and biopharma filtration. The name "Solventum" is intended to convey the idea of unlocking solutions and innovation in the healthcare space.

The planned separation is intended to allow both 3M and Solventum to pursue distinct growth strategies and investment priorities. Solventum is expected to operate as a standalone publicly traded company, with a leadership team and board of directors independent from 3M. The transaction is currently projected to occur in the first half of 2024, subject to final approvals and market conditions.

The businesses comprising Solventum have a history of innovation in their respective fields, and the spin-off is intended to enable a sharper focus on developing and commercializing healthcare technologies to improve patient outcomes and streamline healthcare processes.